Enhancement of interleukin-1β-induced iNOS expression in cultured vascular smooth muscle cells of Goto-Kakizaki diabetes rats

European Journal of Pharmacology

Volumn 629, Issue 1-3, 2010, Pages 1-6

  Wakabayashi, Ichiro ^a   Nakano, Tomoyuki ^a   Takahashi, Yuji ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

(Goto Kakizaki rat); Diabetes mellitus; Extracellular signal regulated kinase; Nitric oxide; Vascular smooth muscle

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRATE; NITRIC OXIDE; NITROGEN DIOXIDE;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL COUNT; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GOTO KAKIZAKI RAT; IMMUNOBLOTTING; IMMUNOCHEMISTRY; IMMUNOCOMPETENT CELL; MALE; MUSCLE FIBER CULTURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; BIOSYNTHESIS; BLOOD; BODY WEIGHT; CELL CULTURE; DIABETES MELLITUS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY;

ANIMALS; AORTA; BLOOD GLUCOSE; BODY WEIGHT; CELLS, CULTURED; DIABETES MELLITUS; ENZYME INDUCTION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERLEUKIN-1BETA; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS;

EID: 74149086725     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.054     Document Type: Article

References (30)

1. Alfon J., Guasch J.F., Berrozpe M., and Badimon L. Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors. Atherosclerosis 145 (1999) 325-331
2. Beckman J.A., Creager M.A., and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287 (2002) 2570-2581
3. Behr-Roussel D., Rupin A., Simonet S., Bonhomme E., Coumailleau S., Cordi A., Serkiz B., Fabiani J.N., and Verbeuren T.J. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-l-lysine or with l-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation 102 (2000) 1033-1038
4. Calver A., Collier J., and Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest. 90 (1992) 2548-2554
5. Carmo A., Cunha-Vaz J.G., Carvalho A.P., and Lopes M.C. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide 4 (2000) 590-596
6. Diederich D., Skopec J., Diederich A., and Dai F.X. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am. J. Physiol. 266 (1994) H1153-H1161
7. Esaki T., Hayashi T., Muto E., Yamada K., Kuzuya M., and Iguchi A. Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis 128 (1997) 39-46
8. Ginnan R., Guikema B.J., Singer H.A., and Jourd'heuil D. PKC-δ mediates activation of ERK1/2 and induction of iNOS by IL-1β in vascular smooth muscle cells. Am. J. Physiol., Cell Physiol. 290 (2006) C1583-C1591
9. Guikema B.J., Ginnan R., Singer H.A., and Jourd'heuil D. Catalase potentiates interleukin-1β-induced expression of nitric oxide synthase in rat vascular smooth muscle cells. Free Radic. Biol. Med. 38 (2005) 597-605
10. Hattori Y., Kawasaki H., Abe K., and Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 261 (1991) H1086-H1094
11. Jiang B., Brecher P., and Cohen R.A. Persistent activation of nuclear factor-kB by interleukin-1β and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1915-1920
12. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., and Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88 (1993) 2510-2516
13. Kamata K., Miyata N., Abiru T., and Kasuya Y. Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci. 50 (1992) 1379-1387
14. Kleschyov A.L., Muller B., Schott C., and Stoclet J.C. Role of adventitial nitric oxide in vascular hyporeactivity induced by lipopolysaccharide in rat aorta. Br. J. Pharmacol. 124 (1998) 623-626
15. Landmesser U., Hornig B., and Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 109 suppl II (2004) II27-II33
16. 2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 295 (2008) R144-R154
17. Lee J.H., Palaia T., and Ragolia L. Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation. Am. J. Physiol., Cell Physiol. 296 (2009) C327-C338
18. Matsumoto T., Ishida K., Nakayama N., Kobayashi T., and Kamata K. Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat. Am. J. Physiol., Heart Circ. Physiol. 296 (2009) H1388-H1397
19. Napoli C., de Nigris F., Williams-Ignarro S., Pignalosa O., Sica V., and Ignarro L.J. Nitric oxide and atherosclerosis: an update. Nitric Oxide 15 (2006) 265-279
20. Oyama Y., Kawasaki H., Hattori Y., and Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol. 132 (1986) 75-78
21. 2-Adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells. Am. J. Physiol. 274 (1998) C654-C662
22. Salehi A., Meidute Abaraviciene S., Jimenez-Feltstrom J., Östenson C.G., Efendic S., and Lundquist I. Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1. PLoS ONE 3 (2008) e2165
23. Sandu O.A., Ragolia L., and Begum N. Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation. Diabetes 49 (2000) 2178-2189
24. Shimizu S., Ishii M., Kawakami Y., Kiuchi Y., Momose K., and Yamamoto T. Presence of excess tetrahydrobiopterin during nitric oxide production from inducible nitric oxide synthase in LPS-treated rat aorta. Life Sci. 65 (1999) 2769-2779
25. Takahashi Y., Negoro M., and Wakabayashi I. Decreased modulation by lipopolysaccharide of aortic smooth muscle contractility in streptozotocin-induced hyperglycemic rats. J. Cardiovasc. Pharmacol. 41 (2003) 162-170
26. Takahashi Y., Nakano T., and Wakabayashi I. Increased induction of inducible nitric oxide synthase expression in aortae of type 2 diabetes rats. J. Pharmacol. Sci. 107 (2008) 190-200
27. Tierney E.F., Geiss L.S., Engelgau M.M., Thompson T.J., Schaubert D., Shireley L.A., Vukelic P.J., and McDonough S.L. Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota. Am. J. Public Health 91 (2001) 84-92
28. Wei C.Y., Huang K.C., Chou Y.H., Hsieh P.F., Lin K.H., and Lin W.W. The role of Rho-associated kinase in differential regulation by statins of interleukin-1β- and lipopolysaccharide-mediated nuclear factor κβ activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells. Mol. Pharmacol. 69 (2006) 960-967
29. Williams S.B., Cusco J.A., Roddy M.A., Johnstone M.T., and Creager M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 27 (1996) 567-574
30. Zhang H., Du Y., Cohen R.A., Chobanian A.V., and Brecher P. Adventitia as a source of inducible nitric oxide synthase in the rat aorta. Am. J. Hypertens. 12 (1999) 467-475